The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Messaoudi, I.
Right arrow Articles by LeMaoult, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Messaoudi, I.
Right arrow Articles by LeMaoult, J.
The Journal of Immunology, 1999, 163: 3286-3294.
Copyright © 1999 by The American Association of Immunologists

The Mode of Ligand Recognition by Two Peptide:MHC Class I-Specific Monoclonal Antibodies1

Ilhem Messaoudi*,{dagger}, Joël LeMaoult* and Janko Nikolic-ugic2,*,{dagger}

* Laboratory of T Cell Development, Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; and {dagger} Weill Graduate School of Medical Sciences of Cornell University, New York, NY 10021

The Ig superfamily members TCR and B cell receptor (BCR) share high structural and amino acid homology, yet interact with Ags in a distinct manner. The overall shape of the TCR ligand is rather constant, with the variation coming from the MHC polymorphism and the peptide heterogeneity. Consequently, the TCR {alpha}- and ß-chains form a relatively flat ligand-binding site that interacts with the peptide:MHC (pep:MHC) ligand in a fixed diagonal orientation relative to the MHC {alpha}-helices, with the {alpha}- and ß-chains of the TCR contacting the N and C termini of the pep:MHC complex, respectively. By contrast, the shape of BCR ligands varies dramatically, and the BCR exhibits much greater variability of the Ag-binding site. The mAbs 25-D1.16 (D1) and 22-C5.9 (C5), specific for the OVA-8:H-2Kb complex, allowed us to directly compare how TCR and BCR approach the same ligand. To that effect, we mapped D1 and C5 footprints over the OVA-8:H-2Kb complex. Using peptide variants and mutant MHC molecules, we show that the D1 and C5 contacts with the OVA-8:Kb complex C terminus overlap with the TCR ß-chain footprint, but that this footprint also extends to the regions of the molecule not contacted by the TCR. These studies suggest that D1 and C5 exhibit a hybrid mode of pep:MHC recognition, in part similar to that of the TCR ß-chain and in part similar to the conventional anti-MHC Ab.




This article has been cited by other articles:


Home page
J. Immunol.Home page
L. A. Benoit and R. Tan
Xenogeneic beta2-Microglobulin Substitution Affects Functional Binding of MHC Class I Molecules by CD8+ T Cells
J. Immunol., September 15, 2007; 179(6): 3588 - 3595.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. Truscott, L. Lybarger, J. M. Martinko, V. E. Mitaksov, D. M. Kranz, J. M. Connolly, D. H. Fremont, and T. H. Hansen
Disulfide Bond Engineering to Trap Peptides in the MHC Class I Binding Groove
J. Immunol., May 15, 2007; 178(10): 6280 - 6289.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Racape, F. Connan, J. Hoebeke, J. Choppin, and J.-G. Guillet
Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation
PNAS, November 28, 2006; 103(48): 18208 - 18213.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Mulder, C. Eijsink, M. G. D. Kester, M. E. I. Franke, M. J. Kardol, M. H. M. Heemskerk, C. van Kooten, F. A. Verreck, J. W. Drijfhout, F. Koning, et al.
Impact of Peptides on the Recognition of HLA Class I Molecules by Human HLA Antibodies
J. Immunol., November 1, 2005; 175(9): 5950 - 5957.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Hulsmeyer, P. Chames, R. C. Hillig, R. L. Stanfield, G. Held, P. G. Coulie, C. Alings, G. Wille, W. Saenger, B. Uchanska-Ziegler, et al.
A Major Histocompatibility Complex{middle dot}Peptide-restricted Antibody and T Cell Receptor Molecules Recognize Their Target by Distinct Binding Modes: CRYSTAL STRUCTURE OF HUMAN LEUKOCYTE ANTIGEN (HLA)-A1{middle dot}MAGE-A1 IN COMPLEX WITH FAB-HYB3
J. Biol. Chem., January 28, 2005; 280(4): 2972 - 2980.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Laugel, J. M. Boulter, N. Lissin, A. Vuidepot, Y. Li, E. Gostick, L. E. Crotty, D. C. Douek, J. Hemelaar, D. A. Price, et al.
Design of Soluble Recombinant T Cell Receptors for Antigen Targeting and T Cell Inhibition
J. Biol. Chem., January 21, 2005; 280(3): 1882 - 1892.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. J. Miley, I. Messaoudi, B. M. Metzner, Y. Wu, J. Nikolich-Zugich, and D. H. Fremont
Structural Basis for the Restoration of TCR Recognition of an MHC Allelic Variant by Peptide Secondary Anchor Substitution
J. Exp. Med., December 6, 2004; 200(11): 1445 - 1454.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. E. Biddison, R. V. Turner, S. J. Gagnon, A. Lev, C. J. Cohen, and Y. Reiter
Tax and M1 Peptide/HLA-A2-Specific Fabs and T Cell Receptors Recognize Nonidentical Structural Features on Peptide/HLA-A2 Complexes
J. Immunol., September 15, 2003; 171(6): 3064 - 3074.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Lybarger, Y. Y. L. Yu, M. J. Miley, D. H. Fremont, N. Myers, T. Primeau, S. M. Truscott, J. M. Connolly, and T. H. Hansen
Enhanced Immune Presentation of a Single-chain Major Histocompatibility Complex Class I Molecule Engineered to Optimize Linkage of a C-terminally Extended Peptide
J. Biol. Chem., July 11, 2003; 278(29): 27105 - 27111.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Jankovic, K. Remus, A. Molano, and J. Nikolich-Zugich
T Cell Recognition of an Engineered MHC Class I Molecule: Implications for Peptide-Independent Alloreactivity
J. Immunol., August 15, 2002; 169(4): 1887 - 1892.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Y. L. Yu, N. Netuschil, L. Lybarger, J. M. Connolly, and T. H. Hansen
Cutting Edge: Single-Chain Trimers of MHC Class I Molecules Form Stable Structures That Potently Stimulate Antigen-Specific T Cells and B Cells
J. Immunol., April 1, 2002; 168(7): 3145 - 3149.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Messaoudi, J. LeMaoult, B. M. Metzner, M. J. Miley, D. H. Fremont, and J. Nikolich-Zugich
Functional Evidence That Conserved TCR CDR{{alpha}}3 Loop Docking Governs the Cross-Recognition of Closely Related Peptide:Class I Complexes
J. Immunol., July 15, 2001; 167(2): 836 - 843.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Polakova, D. Plaksin, D. H. Chung, I. M. Belyakov, J. A. Berzofsky, and D. H. Margulies
Antibodies Directed Against the MHC-I Molecule H-2Dd Complexed with an Antigenic Peptide: Similarities to a T Cell Receptor with the Same Specificity
J. Immunol., November 15, 2000; 165(10): 5703 - 5712.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. U.Y. Lee, H. R.O. Churchill, M. Daniels, S. C. Jameson, and D. M. Kranz
Role of 2c T Cell Receptor Residues in the Binding of Self-And Allo-Major Histocompatibility Complexes
J. Exp. Med., April 17, 2000; 191(8): 1355 - 1364.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.